Open-Label Study of the Pharmacokinetics of Omacetaxine Mepesuccinate
- Study Title
- An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate
- Teva Identifier
- C41443/1103 Study | 2012-004003-12
- ClinicalTrials.gov Identifier
- NCT01844869
- Study Status
- Completed
- Trial Condition(s)
- Hematologic Malignancies | Solid Tumors
- Interventions
- Drug: omacetaxine mepesuccinate
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 07/01/2013 - 01/01/2015
- Phase
- Phase 1
